ALLO
Price
$1.15
Change
+$0.01 (+0.88%)
Updated
Sep 2, 04:09 PM (EDT)
Capitalization
250.73M
58 days until earnings call
MBRX
Price
$0.38
Change
-$0.01 (-2.56%)
Updated
Sep 2, 04:48 PM (EDT)
Capitalization
11.85M
Interact to see
Advertisement

ALLO vs MBRX

Header iconALLO vs MBRX Comparison
Open Charts ALLO vs MBRXBanner chart's image
Allogene Therapeutics
Price$1.15
Change+$0.01 (+0.88%)
Volume$300
Capitalization250.73M
Moleculin Biotech
Price$0.38
Change-$0.01 (-2.56%)
Volume$3.21K
Capitalization11.85M
ALLO vs MBRX Comparison Chart in %
Loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALLO vs. MBRX commentary
Sep 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a Hold and MBRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2025
Stock price -- (ALLO: $1.13 vs. MBRX: $0.39)
Brand notoriety: ALLO and MBRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 74% vs. MBRX: 66%
Market capitalization -- ALLO: $250.73M vs. MBRX: $11.85M
ALLO [@Biotechnology] is valued at $250.73M. MBRX’s [@Biotechnology] market capitalization is $11.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileMBRX’s FA Score has 0 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • MBRX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALLO and MBRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 4 TA indicator(s) are bullish while MBRX’s TA Score has 4 bullish TA indicator(s).

  • ALLO’s TA Score: 4 bullish, 5 bearish.
  • MBRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ALLO is a better buy in the short-term than MBRX.

Price Growth

ALLO (@Biotechnology) experienced а -5.04% price change this week, while MBRX (@Biotechnology) price change was -30.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.60%. For the same industry, the average monthly price growth was +22.12%, and the average quarterly price growth was +32.72%.

Reported Earning Dates

ALLO is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+6.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALLO($251M) has a higher market cap than MBRX($11.9M). ALLO YTD gains are higher at: -46.948 vs. MBRX (-76.918). MBRX has higher annual earnings (EBITDA): -25.32M vs. ALLO (-223.22M). ALLO has more cash in the bank: 273M vs. MBRX (7.56M). MBRX has less debt than ALLO: MBRX (420K) vs ALLO (79.2M). ALLO (0) and MBRX (0) have equivalent revenues.
ALLOMBRXALLO / MBRX
Capitalization251M11.9M2,109%
EBITDA-223.22M-25.32M882%
Gain YTD-46.948-76.91861%
P/E RatioN/AN/A-
Revenue00-
Total Cash273M7.56M3,613%
Total Debt79.2M420K18,857%
FUNDAMENTALS RATINGS
ALLO vs MBRX: Fundamental Ratings
ALLO
MBRX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
8898
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
90n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALLO's Valuation (97) in the Biotechnology industry is in the same range as MBRX (99) in the Pharmaceuticals Major industry. This means that ALLO’s stock grew similarly to MBRX’s over the last 12 months.

ALLO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MBRX (100) in the Pharmaceuticals Major industry. This means that ALLO’s stock grew similarly to MBRX’s over the last 12 months.

ALLO's SMR Rating (97) in the Biotechnology industry is in the same range as MBRX (100) in the Pharmaceuticals Major industry. This means that ALLO’s stock grew similarly to MBRX’s over the last 12 months.

ALLO's Price Growth Rating (88) in the Biotechnology industry is in the same range as MBRX (98) in the Pharmaceuticals Major industry. This means that ALLO’s stock grew similarly to MBRX’s over the last 12 months.

ALLO's P/E Growth Rating (100) in the Biotechnology industry is in the same range as MBRX (100) in the Pharmaceuticals Major industry. This means that ALLO’s stock grew similarly to MBRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALLOMBRX
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
76%
Momentum
ODDS (%)
Bullish Trend 5 days ago
79%
Bearish Trend 5 days ago
86%
MACD
ODDS (%)
Bullish Trend 5 days ago
73%
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
88%
Advances
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 21 days ago
75%
Declines
ODDS (%)
Bearish Trend 15 days ago
89%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
82%
Bullish Trend 5 days ago
89%
Aroon
ODDS (%)
Bullish Trend 5 days ago
77%
Bearish Trend 5 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ALLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCDA1.980.02
+0.87%
BioCardia Inc.
CINF153.600.20
+0.13%
Cincinnati Financial Corp
CSV43.78-0.10
-0.23%
Carriage Services
SEZL94.60-1.21
-1.26%
Sezzle Inc
ARBE1.30-0.06
-4.41%
Arbe Robotics Ltd

ALLO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLO has been loosely correlated with CRSP. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLO jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLO
1D Price
Change %
ALLO100%
-4.24%
CRSP - ALLO
54%
Loosely correlated
-2.30%
BEAM - ALLO
52%
Loosely correlated
-2.91%
FATE - ALLO
51%
Loosely correlated
-3.70%
NTLA - ALLO
50%
Loosely correlated
-2.11%
RXRX - ALLO
48%
Loosely correlated
-3.39%
More

MBRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBRX has been loosely correlated with ALLO. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MBRX jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBRX
1D Price
Change %
MBRX100%
-0.18%
ALLO - MBRX
37%
Loosely correlated
-4.24%
EDSA - MBRX
35%
Loosely correlated
-2.93%
XLO - MBRX
33%
Loosely correlated
+1.39%
ICU - MBRX
31%
Poorly correlated
+8.29%
UNCY - MBRX
31%
Poorly correlated
-0.24%
More